Luke Pearsall
Medical · Winston-Salem, NCNPI 1134177306
Payments from drug & device makers
Across 71 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$294
- Gilead$199
- Boehringer Ingelheim$154
- Regeneron Healthcare Solutions, Inc.$104
- Merck$64
- Mylan Specialty L.p.$57
- plus $343 from 17 others
What the payments were for
- Food & beverage$1,217100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 20 | $294 |
| Gilead | 11 | $199 |
| Boehringer Ingelheim | 7 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $104 |
| Merck | 4 | $64 |
| Mylan Specialty L.p. | 3 | $57 |
| AstraZeneca | 3 | $41 |
| Pfizer | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| CSL Behring | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Novartis | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Insmed, Inc. | 1 | $16 |
| Shionogi Inc | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| United Therapeutics Corporation | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
How this compares
$1,217 in reported general payments places this provider in the 65th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 357 | $268,778 |
| Breo ElliptaFluticasone/Vilanterol | 207 | $106,069 |
| Spiriva RespimatTiotropium Bromide | 128 | $77,550 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 84 | $62,882 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 99 | $51,340 |
| SymbicortBudesonide/Formoterol Fumarate | 93 | $35,750 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 37 | $19,847 |
| Spiriva HandihalerTiotropium Bromide | 17 | $18,777 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $15,762 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 24 | $15,012 |
| EliquisApixaban | 19 | $11,070 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 297 | $8,372 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 42 | $7,785 |
| Ventolin HfaAlbuterol Sulfate | 93 | $5,051 |
| BreynaBudesonide/Formoterol Fumarate | 12 | $3,812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $294 | $413,287637 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $154 | $143,902251 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $41 | $98,632177 claims |
| PfizerEliquis | $36 | $11,07019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 878 medical providers in North Carolina.
Other medical in Winston-Salem
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.